Securities code: Shanghai Junshi Biosciences Co.Ltd(688180) securities abbreviation: Shanghai Junshi Biosciences Co.Ltd(688180) Announcement No.: pro 2022009 Shanghai Junshi Biosciences Co.Ltd(688180)
Plan for issuing A-Shares to specific objects in 2022
Suggestive announcement of disclosure
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Shanghai Junshi Biosciences Co.Ltd(688180) (hereinafter referred to as “the company”) held the seventh meeting of the third board of directors and the sixth meeting of the third board of supervisors on March 7, 2022. The meeting deliberated and approved the relevant proposals on the company’s issuance of A-Shares to specific objects in 2022. Relevant documents such as the 2022 plan of Shanghai Shanghai Junshi Biosciences Co.Ltd(688180) Pharmaceutical Technology Co., Ltd. to issue A-Shares to specific objects, the demonstration and analysis report of Shanghai Shanghai Junshi Biosciences Co.Ltd(688180) Pharmaceutical Technology Co., Ltd. to issue A-Shares to specific objects in 2022 and other relevant documents have been posted on the website of Shanghai Stock Exchange（ http://www.sse.com.cn. ）Disclosure, please pay attention to the majority of investors.
The disclosure of the company’s plan to issue A-Shares to specific objects in 2022 does not represent the substantive judgment, confirmation or approval of the audit and registration departments on matters related to this issuance, The effectiveness and completion of the matters related to this issuance described in the plan for issuing A-Shares to specific objects have yet to be considered by the general meeting of shareholders of the company and reviewed by Shanghai Stock Exchange, and registered with China Securities Regulatory Commission.
Please pay attention to investment risks.
It is hereby announced.
Shanghai Junshi Biosciences Co.Ltd(688180) board of directors March 8, 2022
